Legal & General Group
CLYM

Legal & General Group’s Climb Bio CLYM Stock Holding History

Legal & General Group’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$44.6K Buy
+3,419
New +$35.3K ﹤0.01% 2804
2025
Q2 		– Sell
-2,581
Closed -$3.16K – 3575
2025
Q1 		$3.16K Hold
2,581
– – ﹤0.01% 3327
2024
Q4 		$4.63K Hold
2,581
– – ﹤0.01% 3341
2024
Q3 		$13.1K Buy
2,581
+1,950
+309% +$13.8K ﹤0.01% 3207
2024
Q2 		$4.52K Buy
+631
New +$4.2K ﹤0.01% 3384
2022
Q3 		– Sell
-560
Closed -$2K – 3496
2022
Q2 		$2K Sell
560
-99
-15% -$468 ﹤0.01% 3493
2022
Q1 		$5K Hold
659
– – ﹤0.01% 3512
2021
Q4 		$7K Hold
659
– – ﹤0.01% 3526
2021
Q3 		$12K Buy
+659
New +$13.6K ﹤0.01% 3424

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Legal & General Group's CLYM Position: Q2 2026 in Review

Legal & General Group opened a new position in Climb Bio (CLYM) in Q2 2026: 3,419 shares worth $44.6K. The stake represents ﹤0.01% of the portfolio and ranks #2804 among its holdings. This is a return to the name: Legal & General Group previously reported a position in CLYM as recently as Q1 2025.

Legal & General Group first reported a position in CLYM in Q3 2021 and has held it in 9 quarters since. 108 funds tracked by Wall St. Rank hold CLYM as of Q2 2026.

  • Legal & General Group held 3,419 shares of Climb Bio worth $44.6K as of Q2 2026.
  • Climb Bio was a new Legal & General Group position in Q2 2026.
  • Climb Bio made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #2804 holding.
  • Legal & General Group first reported a position in Climb Bio in Q3 2021 and has held it in 9 quarters since.
  • 108 funds tracked by Wall St. Rank held Climb Bio as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.